Key Takeaways GSK's risvutatug rezetecan earns FDA Orphan Drug Designation for treating small-cell lung cancer.The drug also holds FDA Breakthrough and EMA PRIME status supporting accelerated development.Phase III studies are underway following positive ARTEMIS-001 data.GSK plc (GSK) announced that the FDA has granted Orphan Drug Designation to GSK’227, its investigational B7-H3-targeted antibody-drug conjugate (“ADC”), for the treatment of small-cell lung cancer (SCLC). GSK’227 has now been renamed risvuta ...

In this piece, we will look at the 13 best ADR stocks to invest in.ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America. While standard equities are issued by the firm itself, ADRs are issued by US banks that hold the corresponding shares in their overseas branches.The key purpose of ADRs is that they allow investors in America to benefit from trading the shares of foreign companies. These companies ar ...